Podcast


Presenter: G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD Nicolas Dugré PharmD MSc BCPAC

In episode 516, James and Mike invite Nicolas Dugré to the podcast yet again, and this time we talk about the evidence around the latest long-acting implantable reversible contraception. As always, we talk about the efficacy, the harm and all the rest of the issues around the use of these forms of contraception. Show Notes…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

In the Clinic Episode #33: Smoking Cessation

In this episode of In the Clinic, Mike and Jess invite back Dr. Émélie Braschi. The team discusses Xiao Yun, a 68-year old male patient who is trying to quit smoking To earn…
Listen 0.5 credits available

In the Clinic Episode #32: Pediatric Asthma

In this episode of In the Clinic, Mike and Jess invite back Dr. Jennifer Young. The team discusses Brea Salter, a 4-year old girl presenting with wheezing. To earn an additional 0.25…
Listen 0.5 credits available

BS Medicine Episode #592: Pharm for Fibro: Can antidepressants ease the pain?

In episode 592, Mike and James invite Jennifer Young back to the podcast to review the evidence around the use of antidepressants in the challenging pain condition of fibromyalgia. We…
Listen 0.5 credits available

Presenter(s):

G. Michael Allan MD CCFP James McCormack BSc(Pharm) PharmD Nicolas Dugré PharmD MSc BCPAC

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • G. Michael Allan MD CCFP
  • James McCormack BSc(Pharm) PharmD
  • Nicolas Dugré PharmD MSc BCPAC

Spearkers do not have any conflicts of interest to declare.